파멥신
Edit

파멥신

http://www.pharmabcine.com/
Last activity: 24.01.2024
Categories: BioTech
2008년 설립 이후, 차세대 항암 항체신약 개발에 주력해 올린베시맵과 다양한 신약 후보물질의 개발 및 사업화 기반을 구축했습니다. 파멥신은 비면역 scFv 파아지 디스플레이 라이브러리를 활용한 항체 개발 기술과 차세대 이중표적항체 제조기술 그리고 암 줄기세포 라이브러리를 활용한 항체 제조기술 등 혁신적인 바이오 핵심 기술을 보유하고 있습니다. 파멥신은 자체 기술력을 기반으로 임상개발 단계를 진행하고 글로벌 블록버스터 바이오신약 출시를 목표로 합니다. 이를 위해 지속적이고 혁신적인 파이프라인 개발을 통해 대한민국을 대표하는 글로벌 바이오 벤처기업으로 성장해나갈 것입니다.
Likes
802
Mentions
35
Location: South Korea, Daejeon
Employees: 51-200
Phone: 042-863-2017
Founded date: 2008
Facebook
LinkedIn
Youtube
Email

Investors 4

Mentions in press and media 35

DateTitleDescriptionSource
24.01.2024PharmAbcine Announces First Patient Dosed in Phase 1a/b Clin...Initiation of Phase 1a/b clinical trial exploring MTD, RP2D, safety and tolerability of PMC-309 mono...en.prnasia...
23.11.2023PharmAbcine Publishes Study in Science Advances Demonstratin...Study reveals a promising avenue for addressing Idiopathic Systemic Capillary Leak Syndrome (ISCLS, ...en.prnasia...
09.11.2023PharmAbcine Receives Safety Review Committee Approval to Adv...Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the ...en.prnasia...
26.07.2023PharmAbcine Announces First Patient Dosed in the Phase I Cli...DAEJEON, South Korea, July 26, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-...en.prnasia...
23.05.2023PharmAbcine Receives IND Approval from the Korean MFDS for P...DAEJEON, South Korea, May 23, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-s...en.prnasia...
08.05.2023PharmAbcine to participate in "BIO International Conven...DAEJEON, South Korea, May 8, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-st...en.prnasia...
12.12.2022PharmAbcine Announces Collaboration Agreement with MSD to Ev...DAEJEON, South Korea, Dec. 12, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-...en.prnasia...
08.12.2022PharmAbcine to Participate in the 41th Annual J.P. Morgan He...DAEJEON, South Korea, Dec. 8, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-s...en.prnasia...
17.10.2022PharmAbcine Announces Poster Presentations on Its anti-VISTA...DAEJEON, South Korea, Oct. 17, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-...en.prnasia...
26.09.2022PharmAbcine to Participate in BIO-Europe 2022DAEJEON, South Korea, Sept. 26, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical...en.prnasia...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In